Automated Breach and Attack Simulation (ABAS) Market Growth, Trends and Driving Growth
Luton, Bedfordshire, United Kingdom, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Breach and attack simulation (BAS) tools play a crucial role in proactive cybersecurity by continuously simulating real-world attack scenarios. This helps organizations detect vulnerabilities and assess their defenses, ensuring robust systems that can withstand cyber threats. Continuous testing also allows for regular updates to security protocols, adapting to evolving threats.
Access PDF Sample Report (Including Graphs, Charts & Figures) @
https://exactitudeconsultancy.com/reports/45581/automated-breach-and-attack-simulation-abas-market-#request-a-sample
The market is driven by advancements in AI and ML, which enhance the capabilities of BAS tools. These technologies enable simulations of sophisticated attack scenarios with greater precision and real-time analysis, reducing manual testing efforts. AI and ML also help BAS tools learn from past data and adapt to emerging threats, ensuring up-to-date defenses.
As organizations undergo digital transformations, adopting cloud computing, IoT, and mobile platforms, BAS tools become essential in managing the growing complexity and expanding attack surfaces of modern IT environments. They provide scalable, automated testing to safeguard these dynamic infrastructures.
Market Drivers
Escalating Cybersecurity Threats: The growing sophistication and frequency of cyberattacks—such as ransomware, phishing, and advanced persistent threats—are prompting organizations to adopt ABAS solutions to proactively identify and address vulnerabilities.
Regulatory Compliance: Stringent global data protection regulations are pushing organizations to implement advanced security measures, making ABAS an essential tool for ensuring compliance and protecting sensitive information.
Technological Advancements: The integration of AI and machine learning into ABAS platforms is significantly enhancing their ability to simulate complex attack scenarios and providing deeper insights into potential security gaps.
Market Challenges
Lack of Skilled Professionals: Implementing and managing ABAS solutions requires specialized expertise, and the shortage of skilled cybersecurity professionals poses a significant challenge for organizations.
Complexity and Cost: The integration of ABAS solutions into existing security infrastructures can be complex and expensive, particularly for small and medium-sized enterprises (SMEs), which may struggle with budget constraints.
Regulatory Compliance: While data protection regulations are a driver for ABAS adoption, organizations must also ensure compliance with regional and industry-specific standards, which can be resource-intensive.
Market Opportunities
Cloud-Based Solutions: The increasing adoption of cloud computing offers significant opportunities for ABAS providers. Cloud-based solutions offer scalability, flexibility, and cost-effectiveness, making them attractive to organizations looking to enhance their security testing capabilities.
AI and ML Integration: The ongoing development of AI and machine learning presents opportunities to further enhance ABAS platforms, with predictive analytics and automated response mechanisms offering more proactive and adaptive security measures.
Expansion in Emerging Markets: The rapid digitalization in regions like Asia-Pacific is driving demand for robust cybersecurity solutions, providing a lucrative opportunity for ABAS vendors.
Market Segmentation
Offering: In 2023, the platforms and tools segment dominated the market, accounting for over 63% of the share. This segment is expected to continue growing, driven by the ease of integration into existing security infrastructures. The services segment, however, is projected to grow at a CAGR of 40.6% due to increasing demand for expert support in managing complex security environments.
Deployment Mode: Cloud-based solutions held the largest market share of over 54% in 2023, owing to their scalability and flexibility. On-premises deployments are expected to grow at a CAGR of 38.9%, particularly in industries with stringent regulatory requirements.
Application: The threat management application segment led the market, accounting for 34.2% of the share in 2023. The patch management segment is projected to grow at a CAGR of 41.8%, driven by the urgent need to address vulnerabilities in complex IT environments.
Competitive Landscape
The ABAS market is highly competitive, with several key players focusing on innovation and strategic partnerships to maintain a competitive edge. Notable companies include:
SafeBreach: Specializes in continuous security validation platforms to identify vulnerabilities by simulating hacker breach methods.
AttackIQ: Provides a fully managed breach and attack simulation platform, enhancing security posture through continuous assessment and improvement of security controls.
Cymulate: Offers a comprehensive platform to assess security readiness through various attack simulations, including phishing and malware attacks.
XM Cyber: Focuses on hybrid cloud security, providing platforms that continuously expose attack paths across on-premises and multi-cloud networks.
These companies are investing heavily in research and development to integrate advanced features like AI-driven analytics and real-time threat intelligence, ensuring they stay ahead in the competitive cybersecurity landscape.
Browse full Report -
https://exactitudeconsultancy.com/reports/45581/automated-breach-and-attack-simulation-abas-market
Regional Insights (2025-2034)
North America North America is projected to maintain a dominant share of the automated breach and attack simulation (ABAS) market, with continued growth driven by heightened cybersecurity awareness. Organizations in the region increasingly prioritize proactive security measures to detect and resolve vulnerabilities before cyberattacks can occur.
U.S. Trends From 2025 to 2034, the U.S. ABAS market will see significant expansion due to the growing complexity of IT environments. With the rise of interconnected systems—such as cloud services, IoT, and remote work—there is a strong demand for continuous security testing to identify vulnerabilities in real-time and ensure comprehensive protection.
Europe Trends The European market will grow at a CAGR of 40.7% through 2034, propelled by stringent data protection regulations like GDPR. These regulatory frameworks drive the demand for continuous, automated security validation to ensure compliance and safeguard sensitive data.
Asia Pacific Trends Asia Pacific is expected to experience the highest growth, with a CAGR of 43.2% from 2025 to 2034. Rapid digitalization and increasing cybersecurity investments are key drivers. The region's growing number of SMEs further supports market adoption, as smaller enterprises seek scalable and cost-effective BAS solutions to protect their digital assets.
Key Competitors in the ABAS Market
AttackIQ
SafeBreach
Cymulate
XM Cyber
Picus Security
Qualys
Rapid7
FireMon
Keysight Technologies
Skybox Security
IBM Security
ReliaQuest
Fortinet
Mandiant
Sophos
Aujas
Cytomate
Detectify
Scythe
BreachLock
Market Segmentation:● By Offering:
○ Platforms and Tools
○ Services● By Deployment Mode:
○ Cloud-Based
○ On-Premises● By Application:
○ Configuration Management
○ Patch Management
○ Threat Management
○ Others● By End User:
○ Enterprises and Data Centers
○ Managed Service Providers
Market Segmentation Insights
By Offering:
Platforms and Tools
Market Share (2023): Over 65.8%
Key Drivers: The ease of integration into existing security frameworks, along with the incorporation of AI and machine learning, enhances their ability to simulate sophisticated cyber threats efficiently.
Growth Factors: Organizations prefer platforms and tools as they provide continuous security testing without significant changes to infrastructure.
Services
CAGR (Forecast): 40.6%
Key Drivers: Outsourcing security assessments to specialized service providers due to a shortage of in-house cybersecurity expertise.
Growth Factors: Increasing demand for on-demand analyst services and training to assist organizations in handling continuous security challenges.
By Deployment Mode:
Cloud-Based
Market Share (2023): Over 60.5%
Key Drivers: Scalability and flexibility make cloud-based solutions the preferred choice for many enterprises.
Growth Factors: Easier updates and maintenance, along with cost-effectiveness, ensure that security measures remain aligned with evolving threats.
On-Premises
CAGR (Forecast): 38.9%
Key Drivers: Industries with stringent regulatory requirements (e.g., finance and healthcare) prefer on-premises solutions for better control over data.
Growth Factors: Direct oversight of security infrastructure is critical for sectors handling sensitive information.
By Application:
Threat Management
Market Share (2023): 37.1%
Key Drivers: Rising sophistication of cyberattacks such as ransomware and phishing necessitate robust threat management solutions.
Growth Factors: Automated breach and attack simulation tools help proactively identify vulnerabilities before they can be exploited.
Patch Management
CAGR (Forecast): 41.8%
Key Drivers: Remote work and an increase in endpoint devices make patch management crucial for maintaining security.
Growth Factors: Automation helps organizations consistently update devices and minimize entry points for cyber threats.
By End User:
Enterprises and Data Centers
Market Share (2023): Over 64.3%
Key Drivers: The increasing frequency of cyber threats requires enterprises to adopt continuous security validation tools.
Growth Factors: Large organizations use automated breach and attack simulation to maintain a proactive security posture.
Managed Service Providers
CAGR (Forecast): 40.6%
Key Drivers: Managed service providers require robust testing mechanisms to ensure security across multiple client infrastructures.
Growth Factors: ABAS solutions enable these providers to offer comprehensive security assessments, enhancing service delivery and client trust.
Recent developments:
June 2023 - IBM Security launched IBM Security Services for Automated Threat Testing IBM introduced a comprehensive service that enables businesses to automate threat simulations. This service integrates AI-driven threat intelligence and advanced simulation techniques to test security posture across diverse environments. It allows enterprises to proactively identify vulnerabilities and strengthen defenses against sophisticated cyberattacks.September 2023 - Cymulate announced Continuous Security Validation for Cloud Environments Cymulate expanded its platform to include continuous security validation specifically tailored for cloud infrastructures. The enhancement provides real-time breach and attack simulations that allow organizations to ensure robust security in dynamic cloud environments. The service is designed to test configurations, detect vulnerabilities, and support proactive risk mitigation in cloud-based environments.November 2023 - SafeBreach launched SafeBreach Continuous Breach Simulation for Remote Work SafeBreach unveiled an update to its breach and attack simulation platform, focusing on remote work security. With the rise of hybrid work models, the tool automates simulated attacks across dispersed IT environments, ensuring that vulnerabilities in remote work setups are continuously tested and remediated. The update emphasizes endpoint security and cloud access protection.December 2023 - ReliaQuest released Threat Horizon for End-to-End Attack Simulations ReliaQuest launched Threat Horizon, a platform designed to simulate end-to-end attack scenarios across an organization's entire infrastructure. By combining proactive threat simulations with AI-driven analytics, the tool offers deep visibility into potential vulnerabilities and enhances an organization's ability to detect, mitigate, and recover from advanced cyber threats.January 2024 - Mandiant launched Mandiant Security Validation Suite Mandiant introduced the Security Validation Suite, a new offering designed to provide automated breach and attack simulations. This suite integrates seamlessly with existing security technologies, enabling organizations to continuously validate their security measures against emerging threats. The platform utilizes threat intelligence and behavioral analysis to assess and strengthen the effectiveness of an organization's security posture.
This report is also available in the following languages: Japanese (自動化された侵入および攻撃シミュレーション市場), Korean (자동화된 침해 및 공격 시뮬레이션 시장), Chinese (自动入侵和攻击模拟市场), French (Marché de la simulation automatisée de violations et d'attaques), German (Markt für automatisierte Sicherheitsbruch- und Angriffssimulation), and Italian (Mercato della simulazione automatizzata di violazioni e attacchi), etc.Get a Sample PDF Brochure: https://exactitudeconsultancy.com/reports/45581/automated-breach-and-attack-simulation-abas-market-#request-a-sampleMore Related Reports:Automated Breach and Attack Simulation MarketThe automated breach and attack simulation (ABAS) market is experiencing significant growth, driven by the increasing complexity of cyber threats and the necessity for proactive security measures. In 2024, the global ABAS market is valued at approximately USD 447.88 million.https://exactitudeconsultancy.com/reports/45581/automated-breach-and-attack-simulation-abas-market-by-offering-platforms-and-tools-services-deploy#request-a-sample
Over the air testing MarketThe global Over-the-Air (OTA) testing market is experiencing significant growth, driven by the proliferation of wireless technologies and connected devices. In 2024, the market is valued at approximately USD 2.6 billion.https://exactitudeconsultancy.com/reports/45623/over-the-air-ota-testing-market
Soil Monitoring MarketThe global soil monitoring market is experiencing significant growth, driven by the increasing adoption of precision agriculture and the need for sustainable farming practices. In 2024, the market is projected to reach approximately USD 816.71 million, up from USD 712.87 million in 2023.https://exactitudeconsultancy.com/reports/45620/soil-monitoring-market
Intelligent Document Processing MarketThe global intelligent document processing (IDP) market was valued at approximately USD 2.3 billion in 2024.https://exactitudeconsultancy.com/reports/45618/intelligent-document-processing-market
Multichannel Order Management MarketThe global multichannel order management market is projected to experience significant growth from 2025 to 2034. In 2024, the market is estimated to be valued at approximately USD 3.4 billion.https://exactitudeconsultancy.com/reports/45617/multichannel-order-management-market
Video Processing Platform MarketIn 2024, the market is valued at approximately USD 8.3 billion. Projections indicate that by 2034, the market will reach around USD 45.0 billion, reflecting a compound annual growth rate (CAGR) of 18.5% over the forecast period.https://exactitudeconsultancy.com/reports/45616/video-processing-platform-market
Network Probe MarketThe global network probe market was valued at approximately USD 827.82 million in 2024 and is projected to reach around USD 1,755.48 million by 2034, indicating a Compound Annual Growth Rate (CAGR) of about 13.33% during the forecast period.https://exactitudeconsultancy.com/reports/45614/network-probe-market
Crypto Asset Management MarketThe global crypto asset management market was valued at approximately USD 1.0 billion in 2023 and is projected to reach around USD 4.3 billion by 2030, reflecting a compound annual growth rate (CAGR) of 24.6% during the forecast period.https://exactitudeconsultancy.com/reports/45612/crypto-asset-management-market
Inspection Management Software MarketThe global inspection management software market was valued at approximately USD 9.84 billion in 2024 and is projected to reach around USD 27.5 billion by 2034. This represents a compound annual growth rate (CAGR) of approximately 11.8% during the forecast period of 2025–2034.https://exactitudeconsultancy.com/reports/45610/inspection-management-software-market
Graphical User Interface Design Software MarketThe global graphical user interface (GUI) design software market was valued at approximately USD 27.22 billion in 2024.https://exactitudeconsultancy.com/reports/45608/graphical-user-interface-design-software-market
Metaverse MarketProjections indicate significant growth, with the market expected to reach around USD 1,583.87 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 36.35% from 2025 to 2033.https://exactitudeconsultancy.com/reports/45607/metaverse-market
Data Acquisition (DAQ) System MarketThe global Data Acquisition (DAQ) system market was valued at approximately USD 1.96 billion in 2024. Projections indicate that the market will reach around USD 4.8 billion by 2034.https://exactitudeconsultancy.com/reports/45604/data-acquisition-system-market
CONTACT: Contact Data Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@exactitudeconsultancy.comSign in to access your portfolio

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
5 minutes ago
- Business Wire
Drone Battery Market by Technology, Platform, Capacity, Point of Sale and Region
DUBLIN--(BUSINESS WIRE)--The "Drone Battery Market by Technology (Lithium-based, Nickel-based, Fuel Cell, Sodium-ion), Platform (Commercial, Government & Law Enforcement, Military), Capacity (<5, 5-20, 20-50, >50), Point of Sale (OEM, Aftermarket) and Region - Forecast to 2030" has been added to offering. The drone battery market is set to expand significantly, with projections estimating an increase to USD 2.41 billion by 2030 from USD 1.59 billion in 2025, at a CAGR of 8.7%. The growth is driven by the increasing adoption of drone technology across agriculture, delivery services, and defense sectors, necessitating robust, reliable batteries that promise longer operating life, quicker charging times, and safe operations. Innovations in battery technology, specifically Lithium-based batteries and hydrogen fuel cells, are enhancing drone performance, although high costs and sourcing difficulties for materials like Lithium, coupled with stringent transportation regulations, pose challenges. Despite these, the demand for superior drone batteries remains strong, fueling market growth. Cell to be largest segment during forecast period The cell segment dominates the drone battery market. Being pivotal to power storage and supply, the cell component's strength and lightweight characteristics largely dictate drone flight time and operational efficiency. As sectors such as delivery, agriculture, and defense scale their drone usage, the demand for quality, energy-dense, lightweight battery cells increases, compelling manufacturers to advance cell performance for optimal drone utility. Commercial segment to exhibit fastest growth during forecast period The commercial segment of the drone battery market is undergoing rapid expansion. With drones being deployed across various business functions such as delivery, agriculture, inspections, filming, and mapping, the need for powerful batteries that support extended flight times and heavier payloads is rising. Industries including e-commerce, smart farming, construction, and energy inspection are increasingly turning to drones for efficiency gains, thus driving the demand for advanced, application-suited batteries, thereby accelerating growth in the commercial segment. North America to be leading market for drone batteries during forecast period North America is projected to lead the drone battery market, primarily due to its concentration of top drone and battery companies as well as rapid technological adoption. Key sectors such as delivery, agriculture, construction, and security utilize drones extensively, necessitating robust battery development efforts-including innovations in lithium-based batteries and hydrogen fuel cells-to boost flight duration and efficiency. Such broad and high-demand usage solidifies North America's dominion in the global drone battery market. Breakdown of primaries The research drew insights from various industry professionals, encompassing component suppliers, Tier-1 companies, and OEMs, with the primary breakdown as follows: By Company Type: Tier 1 - 35%; Tier 2 - 45%; Tier 3 - 20% By Designation: C Level - 35%; Directors - 25%; Others - 40% By Region: North America - 21%; Europe - 18%; Asia Pacific - 42%; Rest of the World - 19% Epsilor-Electric Fuel Ltd. (Israel), EaglePicher Technologies (US), RRC Power Solutions GmbH (Germany), Shenzhen Grepow Battery Co., Ltd. (China), and Tadiran Batteries (US) are key players within the drone battery market. Research coverage The study evaluates the drone battery market across numerous segments and subsegments, assessing market size and growth potential based on technology, components, capacity, platform, point of sale, and region. Extensive competitive analysis of key players, including company profiles and recent developments, is included to provide market insights. Key benefits of buying this report: This report offers market leaders and new entrants insights into revenue estimates for the drone battery market and its subsegments. It covers the entire market ecosystem, enabling stakeholders to understand the competitive landscape, gain deeper insights for business positioning, and devise effective market strategies. It assists in understanding market dynamics by providing key drivers, constraints, challenges, and opportunities. The report provides insights on the following pointers: Key drivers analysis: Growing drone use, demand for longer flight times and faster charging, smart battery advancements, autonomous technology adoption, and cleaner operations. Product Development: Detailed analysis of innovation and developments by regional companies. Market Development: Insightful analysis of lucrative markets across diverse regions. Market Diversification: Comprehensive data on new solutions, unexplored regions, developments, and investments in the drone battery market. Competitive Assessment: Detailed evaluation of top players' market shares, growth strategies, and product offerings, including companies like Epsilor-Electric Fuel Ltd., EaglePicher Technologies, RRC Power Solutions GmbH, Shenzhen Grepow Battery Co., Ltd., and Tadiran Batteries. Key Attributes: Key Topics Covered: 5 Market Dynamics Drivers Growing Adoption of Drones Across Diverse Applications Increasing Demand for Longer Flight Times, Faster Charging, and Safer Battery Performance Advancements in Autonomous Drone Technology Restraints High Cost of Energy-Dense Batteries Restrictions on Transport of Lithium Batteries Limited Battery Lifespan and Flight Time Opportunities Advancements in Material Sciences and Battery Technology Innovations in Hydrogen Fuel Cell Technology Introduction of Smart Battery Technology Public and Private Sector Investments in Drone Battery R&D and Local Manufacturing Challenges Inadequate Charging Infrastructure Lack of Safety Standards Poor Quality of Grey Market Products Case Studies Iss Aerospace's Sensus Employed Hydrogen Fuel Cells to Enhance Range and Flight Time Thales' Stratobus Leveraged Licerion-He Batteries to Enhance Operations Storedot Developed Ufc Flashbettery to Reduce Charging Time Maxell and Nileworks Developed Intelligent Batteries for Agricultural Drones Danenergy Designed Custom Lithium Battery Packs to Enhance Performance 13 Company Profiles Dji Eaglepicher Technologies Rrc Power Solutions GmbH Shenzhen Grepow Battery Co. Ltd. Epsilor-Electric Fuel Ltd. Tadiran Batteries Plug Power Inc. Ses Ai Corporation Sion Power Corporation Intelligent Energy Limited H3 Dynamics Holdings Pte. Ltd. Honeywell International Inc. Inventus Power Mmc Doosan Mobility Innovation Other Players Kokam Battery Denchi Group Troowin Power System Technology Amperex Technology Limited Amicell Custom Power Amprius Technologies Guangzhou Sunland New Energy Technology Co. Ltd. Alexander Battery Technologies Ev Battery Solutions For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Yahoo
25 minutes ago
- Yahoo
ZenaTech Unveils New Quantum Computing Division to Accelerate Advanced Drone and Defense Capabilities
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces the formation of its new Quantum Computing Division. The new division will focus on development of R&D initiatives that harness the next generation of computing power to solve very complex challenges in modern defense and autonomous drone systems that can utilize ZenaDrone's drone solutions. The US Department of Defense, along with other federal agencies, has called for advancements in quantum-resistant communications, post-quantum cybersecurity, and quantum sensing for drone navigation in GPS-denied environments to ensure US defence and aerospace superiority. In line with these priorities, ZenaTech's Quantum Computing Division will focus on the development of both hardware and software quantum innovations for use cases such as encryption and secure communications for mission-critical operations, enhanced navigation without GPS, and AI drone fleet optimization for a variety of ISR (Inspection, Surveillance and Reconnaissance) defense applications. 'We believe quantum computing will be a defining force in the next era of defense and aerospace innovation,' said Shaun Passley, Ph.D., ZenaTech CEO. 'Establishing a Quantum Computing Division is a strategic investment in our future. By advancing cybersecurity, secure communications, next-generation navigation, and massive-scale data processing, we are preparing our drone platforms for the challenges of tomorrow and contributing to America's global defense leadership.' The current 12-person quantum team will grow to 20 by year-end consisting of a multidisciplinary team of AI and machine learning experts, quantum hardware researchers, computational scientists, and professionals in physics, computer science, engineering, and systems design. ZenaTech's Quantum Computing Division will also further two existing Quantum R&D projects. The Sky Traffic project is focused on the use of AI-enabled drones and quantum computing to optimize traffic flows and support public safety for government applications. The Clear Sky project is focused on leveraging AI drone swarms and quantum computing to improve localized weather forecasts and extreme weather predictions, helping save lives and reduce economic losses. The ZenaDrone 1000 is a medium-sized VTOL platform drone capable of carrying up to 40 kg, featuring AI-enabled autonomy, secure communications via DroneNet, and rugged construction. Designed for BVLOS (Beyond Visual Line of Sight) operations, it supports specialized cargo delivery, inspections, precision agriculture, and defense applications including ISR missions. The company has previously completed paid trials with the US Air Force and Navy Reserve and is developing a gas-powered variant for extended flight missions and border patrol. Quantum computing is an emergent field of cutting-edge computer science, harnessing the unique qualities of quantum mechanics to solve problems beyond the capabilities of even the most powerful classical computers, processing massively complex mathematical problems and data at orders of magnitude faster speeds. Quantum computers can analyze vast and complex drone data more quickly and accurately, improving weather predictions and enhancing the ability to forecast extreme events. About ZenaTech ZenaTech (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company specializing in AI drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions for mission-critical business applications. Since 2017, the Company has leveraged its software development expertise and grown its drone design and manufacturing capabilities through ZenaDrone, to innovate and improve customer inspection, monitoring, safety, security, compliance, and surveying processes. With enterprise software customers using branded solutions in law enforcement, health, government, and industrial sectors, and drones being implemented in these plus agriculture, defense, and logistics sectors, ZenaTech's portfolio of solutions helps drive exceptional operational efficiencies, accuracy, and cost savings. The Company operates through global offices in North America, Europe, Taiwan, and UAE, and is growing its US DaaS business model and network of locations through acquisitions. About ZenaDrone ZenaDrone, a wholly owned subsidiary of ZenaTech, develops and manufactures autonomous business drone solutions that can incorporate machine learning software, AI, predictive modeling, Quantum Computing, and other software and hardware innovations. Created to revolutionize the hemp farming sector, its specialization has grown to multifunctional drone solutions for industrial surveillance, monitoring, inspection, tracking, process automation and defense applications. Currently, the ZenaDrone 1000 drone is used for crop management applications in agriculture and critical field cargo applications in the defense sector, the IQ Nano indoor drone is used for inventory management and security in the warehouse and logistics sectors, and the IQ Square is an outdoor drone designed for land surveys and inspections use in commercial and defense sectors. Contacts for more information: Company, Investors, and Media:Linda MontgomeryZenaTech312-241-1415investors@ Investors:Michael MasonCORE IRinvestors@ Safe Harbor This press release and related comments by management of ZenaTech, Inc. include 'forward-looking statements' within the meaning of U.S. federal securities laws and applicable Canadian securities laws. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. This forward-looking information relates to future events or future performance of ZenaTech and reflects management's expectations and projections regarding ZenaTech's growth, results of operations, performance, and business prospects and opportunities. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management. In some cases, forward-looking information can be identified by terminology such as 'may', 'will', 'should', 'expect', 'plan', 'anticipate', 'aim', 'seek', 'is/are likely to', 'believe', 'estimate', 'predict', 'potential', 'continue' or the negative of these terms or other comparable terminology intended to identify forward-looking statements. Forward-looking information in this document includes, but is not limited to ZenaTech's expectations regarding its revenue, expenses, production, operations, costs, cash flows, and future growth; expectations with respect to future production costs and capacity; ZenaTech's ability to deliver products to the market as currently contemplated, including its drone products including ZenaDrone 1000 and IQ Nano; ZenaTech's anticipated cash needs and it's needs for additional financing; ZenaTech's intention to grow the business and its operations and execution risk; expectations with respect to future operations and costs; the volatility of stock prices and market conditions in the industries in which ZenaTech operates; political, economic, environmental, tax, security, and other risks associated with operating in emerging markets; regulatory risks; unfavorable publicity or consumer perception; difficulty in forecasting industry trends; the ability to hire key personnel; the competitive conditions of the industry and the competitive and business strategies of ZenaTech; ZenaTech's expected business objectives for the next twelve months; ZenaTech's ability to obtain additional funds through the sale of equity or debt commitments; investment capital and market share; the ability to complete any contemplated acquisitions; changes in the target markets; market uncertainty; ability to access additional capital, including through the listing of its securities in various jurisdictions; management of growth (plans and timing for expansion); patent infringement; litigation; applicable laws, regulations, and any amendments affecting the business of in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Clinical Trial Biorepository and Archiving Solutions Market Size Expected to Attain USD 9.69 Billion by 2034
The global clinical trial biorepository and archiving solutions market is valued at USD 4.76 billion in 2025 and is projected to reach approximately USD 9.69 billion by 2034, expanding at a CAGR of 8.21% during the forecast period, according to a study published by Towards Healthcare, a sister company of Precedence Research. Ottawa, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global clinical trial biorepository and archiving solutions market was valued at USD 4.4 billion in 2024 and is projected to reach approximately USD 9.69 billion by 2034, expanding at a CAGR of 8.21%. The market is fueled by accelerating research and development in different fields of healthcare. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America was dominant in the clinical trial biorepository and archiving solutions market by 49% shares in 2024. Asia Pacific is expected to grow at the fastest CAGR during 2025-2034. By service, the biorepository services segment led the market in 2024. By service, the archiving solution services segment is expected to grow notably in the upcoming years. By product, the clinical products segment dominated the clinical trial biorepository and archiving solutions market in 2024. By product, the preclinical products segment is expected to grow at a notable CAGR in the studied years. By phase, the preclinical segment registered dominance in the market in 2024. By phase, the phase II segment is expected to grow at a rapid CAGR during 2025-2034. Market Overview & Potential Primarily, the clinical trial biorepository and archiving solutions market comprises the secure storage and management of biological samples (like blood, tissue, and DNA) and linked data from clinical trials. Alongside, it has widespread application in various areas, like clinical research, pharmaceutical development, and personalized medicine, with the increasing focus on data integrity and regulatory compliance. Apart from this, expanding data management, optimizing sample storage, and enhancing the use of digital solutions for compliance and collaboration are propelling the overall adoption and expansion of clinical trial biorepository and archiving solutions. What are the Major Growth Drivers Involved in The Growth of The Market? The clinical trial biorepository and archiving solutions market is driven by continuous groundbreakings in biobanking technologies, like automation and data analytics, which are boosting the effectiveness and accuracy of biorepository operations. Along with this, the widespread application of centralized biorepositories and cloud-based archiving solutions possesses greater accessibility, collaboration, and data management is also impacting the overall market development. You can place an order or ask any questions, please feel free to contact us at sales@ What are the Key Trends Associated with the Market? The clinical trial biorepository and archiving solutions market is developing due to the requirement for efficient sample management, regulatory guidelines for data integrity, and the growing demand for personalized medicine and genomic research. In February 2025, Charles River and Deciphex extended their global partnership to progress digital pathology offering with exclusive image management solutions. In January 2025, Moffitt Cancer Center, a leading National Cancer Institute-designated comprehensive cancer center, and Cryoport, Inc., a global company in supply chain solutions for the life sciences industry, collaborated to offer CRYOGENE's state-of-the-art biorepository services to Speros in Pasco County, Florida. What is the Arising Challenge in the Market? In the clinical trial biorepository and archiving solutions market, accelerating expenses for the establishment and maintenance of biorepositories are essential. Moreover, this needs wide-range investments in infrastructure technology, such as temperature-controlled storage, as well as participation of specialized personnel are also creating barriers in the market expansion. Eventually, small-scale and emerging organizations may experience these hurdles in their development. Regional Analysis Become a valued research partner with us - How Did North America Dominate the Market in 2024? In 2024, North America held the biggest revenue share of 49% in the clinical trial biorepository and archiving solutions market. This region fosters an advanced pharmaceutical sector, with numerous clinical trials, and a phenomenal network of biobanks and research institutions. Along with this, major investments in the R&D department by leading players in the US and Canada are boosting the comprehensive development. Apart from this, the US FDA's stricter regulatory landscape enables adequate biorepository solutions for sample and data May 2025, Cybin Inc., a clinical-stage advanced neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, announced its participation in the Alliance Global Partners Healthcare Company Showcase. In January 2025, ONCare Alliance and partnered to develop a multi-omics database and biobank to accelerate biomarker discovery in oncology. What to Expect from Asian Countries in Clinical Trial Biorespository and Archiving Solutions Market? Asia Pacific is anticipated to grow at the fastest CAGR in the clinical trial biorepository and archiving solutions market. Several eminent companies of ASAP countries like China, India, and Japan, resulting in a higher demand for specialized biorepository and archiving solutions. Furthermore, they are supporting the development rigorous clinical trials platform globally. Besides this, ongoing advances in biobanking technologies, especially automated sample handling, cryopreservation techniques, and digital archiving, are optimizing the efficiency and reliability of biorepository solutions. For instance, In June 2025, iNGENū CRO entered into a partnership with Quantum BioPharma to launch a pioneering Australian clinical trial for chronic nociplastic pain in MCAS patients. In February 2025, LabConnect and Australian Clinical Labs' (ACL) Specialised Trials forged a strategic collaboration to boost support of clinical trials in Australia and the Asia-Pacific region. Get the latest insights on healthcare industry segmentation with our Annual Membership: Segmental Insights By Service Analysis Why did the Biorepository Services Segment Lead the Market in 2024? The biorepository services segment held a dominating share of the clinical trial biorepository and archiving solutions market in 2024. Primarily, the segment is propelled by the wider demand for biorepository services in oncology research and customized medicine. Along with this, these services are increasingly merged in the safe and secure storage of biological samples, which are vital for biomarker discovery, treatment response analysis, and targeted therapy development. Whereas, various biorepositories are termed as biosample libraries, providing valuable resources for studies focused on enhancing individual patient care and advancing medical knowledge. Although the archiving solution services segment is predicted to expand at a significant CAGR during 2025-2034. This service plays a prominent role in the maintenance of comprehensive patient records and the facilitation of access to historical medical data, which is necessary for precise diagnoses and efficient healthcare delivery. They also manage a large volume of data during clinical trials, comprising lab results, patient records, and imaging data, ensuring data integrity and accessibility. In the security of significant biological samples and data, these services are acting as a major component in the research findings. By Product Analysis How did the Clinical Products Segment Hold the Largest Share of the Market in 2024? In 2024, the clinical products segment led the clinical trial biorepository and archiving solutions market. This segment mainly encompasses diverse products, such as cryogenic vials, tubes, and other containers designed for long-term preservation of biological samples, as well as barcodes, RFID tags, and software to track samples throughout the trial lifecycle. Additionally, specialized containers and equipment for sample handling are important in early-stage research. Also, these kinds of products provide the maintenance of sample viability, prevention of degradation, and allowance for accurate analysis. However, the preclinical products segment will expand significantly during 2025-2034. Across the globe, various ongoing preclinical studies that need strong sample management for toxicology and genetic analysis fuel the demand for advanced biorepository and archiving systems. As well as preclinical biorepositories, it provides controlled environments, including temperature, humidity, etc., to control the integrity of biological samples, such as tissues, cells, and blood, which are major aspects for accurate analysis and validation. Preclinical products usually consist of different technologies and methodologies for processing and preserving samples, maintaining their quality for downstream analysis. This further expands the drug development process. By Phase Analysis How did the Preclinical Segment Dominate the Market in 2024? In the clinical trial biorepository and archiving solutions market, the preclinical segment captured a major revenue share in 2024. The segment is driven by a rise in R&D spending by numerous biopharmaceutical companies, which is resulting in greater preclinical studies and an enhanced need for trustworthy biorepository and archiving solutions. Nowadays, the preclinical studies are widely employed in the growing development of precision medicine, extensive sample analysis. The phase II segment is anticipated to expand rapidly in the coming years. This phase is related to the study of a drug's efficacy, safety, and potential side effects, which requires meticulous archived and connecting with the corresponding biological samples. During this phase, diverse biological samples, like blood, tissue, and other biospecimens, are collected with the application of biorepositories for their storage. Moreover, the segment is impacted by strict regulatory rules for clinical trials, such as those regarding data integrity and sample preservation, which also propel the need for reliable biorepository and archiving solutions. Browse More Insights of Towards Healthcare: The clinical trial investigative site network market was valued at USD 8.36 billion in 2023 and is projected to reach USD 15.99 billion by 2034, expanding at a CAGR of 6.07% from 2024 to 2034. The global cell and gene therapy clinical trials market stood at USD 10.8 billion in 2024, increased to USD 12.47 billion in 2025, and is expected to climb to USD 45.31 billion by 2034, registering a strong CAGR of 15.43% during 2025–2034. The clinical genomics market was valued at USD 1.06 billion in 2024, grew to USD 1.25 billion in 2025, and is anticipated to reach USD 5.34 billion by 2034, expanding at a CAGR of 17.54% between 2025 and 2034. The preclinical advanced cell models market is witnessing strong momentum and is set to generate substantial revenues, with estimates indicating growth into the hundreds of millions by 2034. The AI in clinical trials for drugs market is also on a robust growth path, projected to achieve significant revenue gains, potentially reaching into the hundreds of millions from 2025 to 2034. The clinical data analytics market was valued at USD 81.65 billion in 2024, rose to USD 104.16 billion in 2025, and is forecasted to surge to USD 930.01 billion by 2034, reflecting an impressive CAGR of 27.57% between 2025 and 2034. The clinical trial design market stood at USD 567.66 million in 2024, grew to USD 613.25 million in 2025, and is projected to reach USD 1,228.57 million by 2034, expanding at a CAGR of 8.04% from 2025 to 2034. The preclinical CRO market was valued at USD 6.8 billion in 2025 and is expected to grow to USD 14.34 billion by 2034, advancing at a CAGR of 8.73% during 2025–2034. The core clinical molecular diagnostics market was estimated at USD 5.3 billion in 2023 and is set to reach USD 14.45 billion by 2034, growing at a CAGR of 9.54% between 2024 and 2034. The decentralized clinical trials (DCTs) market stood at USD 8.29 billion in 2023 and is forecasted to rise to USD 38.2 billion by 2034, with a CAGR of 14.9% from 2024 to 2034. Recent Developments In August 2025, Union Minister Dr. Jitendra Singh launched the country's first Animal Stem Cell Biobank at the National Institute of Animal Biotechnology (NIAB), equipped with 3D bioprinting, advanced cryostorage. In May 2025, Sapio Sciences unveiled an innovative Biorepository Management solution, with accelerated sample management capabilities and platform-wide improvements created to simplify lab operations and support high-throughput research environments. In May 2025, Markel Insurance, the insurance operations within Markel Group Inc., launched its Clinical Trials insurance product to provide best-in-class solutions to assist clinical trials research and product development on an international scale. In April 2025, Axtria Inc., an AI-first data analytics innovator transforming life sciences, introduced LUCCID, short for LLM-based Unstructured Clinical Concept Identification, a novel GenAI-powered solution. In January 2025, Stoke Therapeutics announced alignment with global regulatory agencies and plans to initiate a phase 3 study of Zorevunersen as probably the foremost disease-modifying medicine for the treatment of Dravet syndrome. Clinical Trial Biorepository and Archiving Solutions Market Key Players Medpace American Type Culture Collection (ATCC) Cell&Co BioServices (Cryoport) Brooks Life Sciences (Azenta, Inc.) Patheon (Thermo Fisher Scientific, Inc.) Precision Medicine Group, LLC. Labcorp Drug Development Q2 Solutions LabConnect Charles River Laboratories Segments Covered in The Report By Service Biorepository Services Warehousing & storage Transportation Sample Processing Others Archiving Solution Services Database Indexing and Management Scanning & Destruction By Product Preclinical Products Clinical Products Human Tissue Organs Stem cells Other Biospecimens By Phase Preclinical Phase I Phase II Phase III Phase IV By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | PinterestError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data